Delucemine

Delucemine (NPS-1506) is a drug which acts as an NMDA antagonist and a serotonin reuptake inhibitor, and has neuroprotective effects.^[1][2] It was originally investigated for the treatment of stroke and in 2004 was studied as a potential antidepressant.^[3][4][5]

Delucemine

Clinical data
ATC code	none
Identifiers
IUPAC name 3,3-Bis(3-fluorophenyl)-N-methylpropan-1-amine
CAS Number	186495-49-8 Y
PubChem CID	156421
ChemSpider	137745 N
UNII	124LSR3H2X
ChEMBL	ChEMBL2106165 N
CompTox Dashboard (EPA)	DTXSID20171908
Chemical and physical data
Formula	C16H17F2N
Molar mass	261.316 g·mol−1
3D model (JSmol)	Interactive image
SMILES CNCCC(C1=CC(=CC=C1)F)C2=CC(=CC=C2)F
InChI InChI=1S/C16H17F2N/c1-19-9-8-16(12-4-2-6-14(17)10-12)13-5-3-7-15(18)11-13/h2-7,10-11,16,19H,8-9H2,1H3 N Key:MUGNLPWYHGOJEG-UHFFFAOYSA-N N
NY (what is this?)  (verify)

Origin

The structure of delucemine is based on argiotoxin 636, a NMDA antagonist isolated from the venom of Argiope aurantia.^[6][7][8]

See also

• AD-1211
• Budipine
• Diphenidine
• Ephenidine
• Fluorolintane
• Lanicemine
• Methoxphenidine
• MT-45
• Remacemide